ARTV vs AWK · rev $251.0K vs P/E 22, rev $4.65B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported ARTV revenue for 2024-12-31 was $251.0K. Net income was -$65.4M. Revenue was down 99.3% from 2023-12-31 to 2024-12-31. ARTV currently screens at market cap $37.3M.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
ARTV currently screens at market cap $37.3M. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the ARTV and AWK stock pages for the full models.
Not investment advice.